Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Astellas and Medivation begin new phase II MDV-3100 trial in prostate cancer

May 10, 2011

New ALK tyrosine kinase receptor inhibitors presented

May 10, 2011

Favorable preclinical data disclosed on HSP 90 inhibitor MPC-3100

May 10, 2011

Merrimack regains rights to nanoliposomal irinotecan from PharmaEngine

May 10, 2011

Novel CRAC inhibitors presented

May 10, 2011

TGen licenses selective histone deacetylase inhibitors to Oncoholdings

May 9, 2011

Chugai seeks approval for new indications of Herceptin in Japan

May 9, 2011

New IDO-1 inhibitors identified for cancer therapy

May 9, 2011

Siena Biotech patents new Wnt signaling inhibitors

May 9, 2011

FDA approves Afinitor to treat advanced pancreatic neuroendocrine tumors

May 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...